tretinoin - CISMeF

Preferred Label : tretinoin;

MeSH definition : An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE).;

MeSH synonym : trans-retinoic acid; acid, trans-retinoic; acid, retinoic; vitamin a acid; acid, vitamin a; trans retinoic acid; all-trans-retinoic acid; acid, all-trans-retinoic; all trans retinoic acid; Retinoic Acid;

MeSH hyponym : tretinoin zinc salt; beta-all-trans-Retinoic acid; tretinoin potassium salt; tretinoin sodium salt; Potassium Salt, Tretinoin; Salt, Tretinoin Potassium; Salt, Tretinoin Zinc; Zinc Salt, Tretinoin; Acid, beta-all-trans-Retinoic; beta all trans Retinoic Acid; Salt, Tretinoin Sodium; Sodium Salt, Tretinoin;

Related MeSH term : Retin-A; vesanoid; Retin A;

MeSH CAS label : retinoic acid;

MeSH Related Number : tretinoin sodium salt; tretinoin zinc salt; tretinoin potassium salt; 13497-05-7 (Na salt); 22232-80-0 (K salt); 302-79-4 (Tretinoin); 75980-27-7 (Zn salt);

Registry Number MeSH : 302-79-4;

Related CAS MeSH : 13497-05-7 (Tretinoin sodium salt); 75980-27-7 (Tretinoin zinc salt); 22232-80-0 (Tretinoin potassium salt);

Wikipedia link : https://en.wikipedia.org/wiki/Tretinoin;

Codes EINECS : 206-129-0;

Is substance : O;

UNII : 5688UTC01R;

InChIKey : SHGAZHPCJJPHSC-YCNIQYBTSA-N;

Details

Origin ID

D014212;

UMLS CUI

C0040845;

ATC code(s)
- tretinoin [ATC Code]
- tretinoin [ATC Code]
- tretinoin, combinations [ATC Code]
ATC code(s)
- tretinoin [ATC Code]
- tretinoin [ATC Code]
- tretinoin, combinations [ATC Code]
- vitamin b12 and folic acid [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- RETINITIS [WHO-ART Preferred Term]
- Retina [ICHI extension code]
- Retina [ICHI extension code]
- Retina [ICHI target]
- Retina [LOINC System]
- Retina [Anatomie ACR]
- Retina [FMA entity]
- Retina [ICD-O code]
- Retinal [LOINC component]
- Retinoic Acid Agent [NCIt concept]
- Retinoic acid [ICHI extension code]
- Tretinoin [ICHI extension code]
- tretinoin [ATC Code]
CISMeF manual mappings
- Tretinoin adverse reaction (disorder) [SNOMED CT concept]
- tretinoin [Substance BNPC]
Currated CISMeF NLP mapping
- Tretinoin [ICD-11 Extension code]
- Tretinoin [NCIt concept]
- Tretinoin (substance) [SNOMED CT concept]
- tretinoin [SNOMED Notion]
False automatic mappings
- Retina [ICD-11 Extension code]
- Retina [NCIt concept]
- Retinal [NCIt concept]
- Retinal [NCIt concept]
- Retinal structure (body structure) [SNOMED CT concept]
- Retinitis [NCIt concept]
- Retinitis [HPO term]
- Retinitis [MedDRA Preferred Term]
- Retinitis [PASCAL descriptor]
- Retinitis (disorder) [SNOMED CT concept]
- retina [Radlex concept]
- retina [UBERON concept]
- retina [ICF N3 Element]
- retinitis [DO Concept]
- retinitis [Disease (Nov.)]
- retinitis [Radlex concept]
Indexing information
- long noncoding RNA CCDC26, human [MeSH Supplementary Concept]
- ro 23-9223 [MeSH Supplementary Concept]
Pharmacological action(s)
- antineoplastic agents [MeSH Descriptor]
- keratolytic agents [MeSH Descriptor]
Record concept(s)
- Retin-A [MeSH concept]
- beta-all-trans-Retinoic acid [MeSH concept]
- tretinoin [MeSH concept]
- tretinoin potassium salt [MeSH concept]
- tretinoin sodium salt [MeSH concept]
- tretinoin zinc salt [MeSH concept]
- vesanoid [MeSH concept]
Related MeSH Supplementary Concept(s)
- 12-hydroxymethylretinoic acid delta-lactone [MeSH Supplementary Concept]
- 13,14-dihydroretinoic acid [MeSH Supplementary Concept]
- 13-cis-12-(3'-carboxyphenyl)retinoic acid [MeSH Supplementary Concept]
- 14-carboxy-13-cis-retinamide-Sepharose 4B [MeSH Supplementary Concept]
- 3,4-didehydroretinoic acid [MeSH Supplementary Concept]
- 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid [MeSH Supplementary Concept]
- 3-cinnamyl-4-oxoretinoic acid [MeSH Supplementary Concept]
- 3-methyl-4-oxoretinoic acid [MeSH Supplementary Concept]
- 4,4-difluororetinoic acid [MeSH Supplementary Concept]
- 4-(+;-)-(1H-imidazole-1-yl)-N-(4-fluorophenyl)-(E)-retinamide [MeSH Supplementary Concept]
- 4-(1H-imidazol-1-yl)retinoic acid [MeSH Supplementary Concept]
- 4-(1H-imidazol-1-yl)retinoic acid methyl ester [MeSH Supplementary Concept]
- 4-(2-hydroxyethoxy)retinoic acid [MeSH Supplementary Concept]
- 4-(acetylamino)phenylretinoate [MeSH Supplementary Concept]
- 4-(carboethoxyphenyl)retinamide [MeSH Supplementary Concept]
- 4-hydroxyretinoic acid [MeSH Supplementary Concept]
- 4-oxoretinoic acid [MeSH Supplementary Concept]
- 5,6-dihydroxyretinoic acid methyl ester [MeSH Supplementary Concept]
- 5,6-epoxyretinoic acid [MeSH Supplementary Concept]
- 5,6-epoxyretinoyl glucuronide [MeSH Supplementary Concept]
- 5,6-epoxyretinyl palmitate [MeSH Supplementary Concept]
- 5,8-oxyretinoic acid [MeSH Supplementary Concept]
- 7-hydroxymethyl-3,11,15-trimethyl-2,4,6,10,14-hexadecapentaenoic acid [MeSH Supplementary Concept]
- 7-hydroxyretinoic acid [MeSH Supplementary Concept]
- 8-(3'-ethyl-2'-(1-methylethyl)-2'-cyclohexen-1'-ylidene)-3.7-dimethyl-2,4,6-octatrienoic acid [MeSH Supplementary Concept]
- 9,13-retinoic acid [MeSH Supplementary Concept]
- 9-cis-4-oxo-13,14-dihydro-retinoic acid [MeSH Supplementary Concept]
- AIDA protocol [MeSH Supplementary Concept]
- AML92 protocol [MeSH Supplementary Concept]
- DAI protocol [MeSH Supplementary Concept]
- EA-4 (ATRA steroidal analog) [MeSH Supplementary Concept]
- IIF compound [MeSH Supplementary Concept]
- LG 100182 [MeSH Supplementary Concept]
- LPA97R protocol [MeSH Supplementary Concept]
- N-(2-hydroxyethyl)retinamide [MeSH Supplementary Concept]
- N-(2-hydroxyphenyl)retinamide [MeSH Supplementary Concept]
- N-(4-aminosulfonylphenyl)retinamide [MeSH Supplementary Concept]
- N-(4-carboxyphenyl)retinamide [MeSH Supplementary Concept]
- N-(4-methoxyphenyl)retinamide [MeSH Supplementary Concept]
- N-(4-trifluoromethylphenyl)retinamide [MeSH Supplementary Concept]
- N-homocysteine thiolactonyl retinamide [MeSH Supplementary Concept]
- N-phenylretinamide [MeSH Supplementary Concept]
- N-retinoylglucosamine [MeSH Supplementary Concept]
- N-retinoylglycine [MeSH Supplementary Concept]
- N-retinoylleucine [MeSH Supplementary Concept]
- N-retinoylphenylalanine [MeSH Supplementary Concept]
- N-retinoylproline [MeSH Supplementary Concept]
- N1,N12-bis(retinoyl)spermine [MeSH Supplementary Concept]
- atralin gel [MeSH Supplementary Concept]
- bis-retinamido methylpentane [MeSH Supplementary Concept]
- clindamycin, tretinoin drug combination [MeSH Supplementary Concept]
- cupaniol [MeSH Supplementary Concept]
- dimethylmethoxyethylretinoic acid [MeSH Supplementary Concept]
- ethyl retinoate [MeSH Supplementary Concept]
- glucopyranosyl retinoate [MeSH Supplementary Concept]
- methyl 7,8-dihydroretinoate [MeSH Supplementary Concept]
- methyl retinoate [MeSH Supplementary Concept]
- methyl-5,8-epoxyretinoate [MeSH Supplementary Concept]
- motretinide [MeSH Supplementary Concept]
- retinamide [MeSH Supplementary Concept]
- retinoic acid chlorochalcone [MeSH Supplementary Concept]
- retinoid 7901 [MeSH Supplementary Concept]
- retinoid 7902 [MeSH Supplementary Concept]
- retinotaurine [MeSH Supplementary Concept]
- retinoyl fluoride [MeSH Supplementary Concept]
- retinoyl glucuronide [MeSH Supplementary Concept]
- retinoyl glutamate [MeSH Supplementary Concept]
- retinoylalanine [MeSH Supplementary Concept]
- retinoylglucose [MeSH Supplementary Concept]
- retinoyloxymethyl butyrate [MeSH Supplementary Concept]
- retinoylserine [MeSH Supplementary Concept]
- ro 11-503 [MeSH Supplementary Concept]
- ro 11-8284 [MeSH Supplementary Concept]
- ro 12-7554 [MeSH Supplementary Concept]
- ro 12-9933 [MeSH Supplementary Concept]
- ro 23-2895 [MeSH Supplementary Concept]
- ro 23-6457 [MeSH Supplementary Concept]
- ro 8-7699 [MeSH Supplementary Concept]
- tocopheryl retinoate [MeSH Supplementary Concept]
- tocoretinate [MeSH Supplementary Concept]
- trans-retinoyl chloromethane [MeSH Supplementary Concept]
- veltin gel [MeSH Supplementary Concept]
- viaminate [MeSH Supplementary Concept]
- vitamin A acid ethylamide [MeSH Supplementary Concept]
See also
- receptors, retinoic acid [MeSH Descriptor]
See also inter- (CISMeF)
- Product containing tretinoin (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Hazardous or Poisonous Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing tretinoin (medicinal product) [SNOMED CT concept]
- Retinoic Acid [NCIt concept]
- Retinoic acid [ICD-11 Extension code]
- Tretinoin [ICD-11 Extension code]
- Tretinoin [NCIt concept]
- Tretinoin (substance) [SNOMED CT concept]
- tretinoin [ATC Code]
- tretinoin [Substance BNPC]
- tretinoin [SNOMED Notion]
- tretinoin [ATC Code]
Validated automatic mappings to BTNT
- tretinoin [ATC Code]
Validated automatic mappings to NTBT
- Retinoic Acid [NCIt concept]
- Retinoic acid [ICD-11 Extension code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients